111 related articles for article (PubMed ID: 1863937)
1. Antimicrobial activity of seven oral antibiotics against selected community- and hospital-acquired pathogens.
Murray PR
Clin Ther; 1991; 13(2):224-31. PubMed ID: 1863937
[TBL] [Abstract][Full Text] [Related]
2. The choice of empirical antibiotic therapy for nosocomial pneumonia.
Ramirez JA
J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of community and hospital acquired bacteria.
Danchaivijitr S; Dhiraputra C; Rongrungruang Y; Worajitr M; Jintanothaitavorn D
J Med Assoc Thai; 2005 Dec; 88 Suppl 10():S14-25. PubMed ID: 16850635
[TBL] [Abstract][Full Text] [Related]
4. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
Weinstein RA; Nathan C; Delzell D; Kabins SA
Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
8. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
9. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance: patterns and trends in the National University Hospital, Singapore (1989-1991).
Kumarasinghe G; Liew HY; Chow C
Malays J Pathol; 1992 Dec; 14(2):95-103. PubMed ID: 1304631
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of antibiotic resistance in Taiwan, 1998.
Ho M; McDonald LC; Lauderdale TL; Yeh LL; Chen PC; Shiau YR
J Microbiol Immunol Infect; 1999 Dec; 32(4):239-49. PubMed ID: 10650488
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial sensitivity of some gram-negative bacterial strains causing hospital or community-acquired infections].
Usluer G; Başibüyük N; Colak H; Akşit F
Mikrobiyol Bul; 1993 Jul; 27(3):221-7. PubMed ID: 8361411
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activity of ciprofloxacin and netilmicin compared to various antibiotics in Lome, Togo].
Dagnra AY; Prince-David M; Hounkpati A
Sante; 2001; 11(1):63-6. PubMed ID: 11313234
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
Gómez-Martínez J; Marco F; Mensa J; Espasa M; Martínez JA; Jiménez de Anta MT
Rev Esp Quimioter; 1999 Mar; 12(1):54-7. PubMed ID: 10209063
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
[TBL] [Abstract][Full Text] [Related]
19. Frequency and resistance patterns of bacterial isolates from surgical patients in a teaching hospital in Addis Ababa.
Gedebou M; Tassew A; Azene G
Trop Geogr Med; 1983 Jun; 35(2):133-8. PubMed ID: 6351382
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Anastasiou DM; Morgan M; Ruane PJ; Steenbergen JN; Katz BD; Alder JD; Thorne GM
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):339-42. PubMed ID: 18304772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
